Electrophysiologic Phenotype Outperforms Left Ventricular Ejection Fraction for Mortality Prediction in Immune Checkpoint Inhibitor Myocarditis
BACKGROUND: Immune checkpoint inhibitor (ICI)-associated myocarditis carries mortality rates approaching 50%. Risk stratification relies heavily on left ventricular ejection fraction (LVEF), yet many fatal cases occur despite preserved systolic function. OBJECTIVES: The study aims to compare the prognostic value of electrophysiologic involvement vs LVEF in ICI-associated myocarditis. METHODS: We systematically searched PubMed for ICI-associated myocarditis cases with extractable patient-level data. Electrophysiologic phenotype (EP) was defined by clinically significant conduction disease or ventricular arrhythmia, including high-grade atrioventricular block, ventricular tachycardia, ventricular fibrillation, or cardiac arrest. LVEF was dichotomized at ≤35%. Cluster-robust logistic regression was used to assess associations with mortality. RESULTS: From 242 publications, 319 cases were extracted; 180 with complete data comprised the analytical cohort (77 deaths; 42.8% mortality). EP involvement (66.7% of cases) was associated with significantly higher mortality vs EP-negative cases (55.0% vs 18.3%; risk ratio: 3.00; 95% CI: 1.72-5.24; P < 0.001). LVEF ≤35% was not significantly associated with mortality (50.7% vs 38.1%; P = 0.125). Among patients with an LVEF >35%, EP involvement was associated with markedly higher mortality (55.1% vs 11.4%; P < 0.001). In adjusted models, EP remained associated with mortality on both the odds-ratio scale (OR: 5.27; 95% CI: 2.29-12.13; P < 0.001) and risk-ratio scale (RR: 2.94; 95% CI: 1.54-5.59; P < 0.001), whereas LVEF ≤35% was not independently associated with mortality. CONCLUSIONS: Electrophysiologic involvement is a dominant prognostic marker in ICI-associated myocarditis, particularly for risk stratification among patients with an LVEF >35%. Risk stratification should prioritize cardiac rhythm monitoring and identification of conduction abnormalities over reliance on LVEF alone.
Authors
- Taimur Sher (ORCID: https://orcid.org/0000-0003-1133-3970)
- Munir Ghandour (ORCID: https://orcid.org/0000-0001-8338-1942)
- Grace Lin (ORCID: https://orcid.org/0000-0002-8087-1150)
- Asha Ramsakal
- Bakr Alhayek (ORCID: https://orcid.org/0009-0004-6988-9925)
- M Ibrahim (ORCID: https://orcid.org/0009-0001-6493-5302)
- Diya Asad
- Muhammad Umar
- Awais Malik
- Rebekah Alison
- J. Christopher Ray
Institutions
- Twitter (United States) (US)
- Mayo Clinic (US)
- Glasgow Royal Infirmary (GB)
- AdventHealth Tampa (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-10-13
- DOI
- https://doi.org/10.1016/j.jacadv.2026.103337
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00